Also trades as: KRSNAA.NS (NSE) · $vol 1M

₹554.25 ($5.76)

-5.50 (-0.98%)

BSE · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 50 · ₹18.0B mcap · 17M float · 0.056% daily turnover

Revenue

$7.7B +7.8% ▲

5Y CAGR: +14.3%

Gross Profit

$3.0B -45.0% ▼

5Y CAGR: -0.8%

Operating Income

$1.2B +17.3% ▲

5Y CAGR: +16.4%

Net Income

$1.0B +30.7% ▲

5Y CAGR: -11.3%

EPS (Diluted)

$30.88 +31.1% ▲

5Y CAGR: -12.1%

EBITDA

$2.6B +18.3% ▲

5Y CAGR: -6.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$4.6B	$4.9B	$6.2B	$7.2B	$7.7B
YoY Growth	+14.9%	+7.0%	+27.2%	+15.7%	+7.8%
Cost of Revenue	$603M	$742M	$4.1B	$1.7B	$4.7B
Gross Profit	$4.0B	$4.1B	$2.0B	$5.5B	$3.0B
Gross Margin	86.8%	84.8%	33.0%	76.4%	39.0%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$83M	$113M	$130M	$2.0B	$1.8B
Operating Expenses	$3.0B	$3.4B	$1.3B	$1.4B	$1.8B
Operating Income	$909M	$703M	$712M	$1.0B	$1.2B
Operating Margin	20.0%	14.4%	11.5%	14.4%	15.7%
Interest Expense	$185M	$77M	$165M	$247M	$344M
Income Before Tax	$865M	$802M	$700M	$1.0B	$1.3B
Tax Expense	$181M	$181M	$132M	$251M	$289M
Net Income	$684M	$621M	$568M	$776M	$1.0B
Net Margin	15.0%	12.8%	9.2%	10.8%	13.1%
EPS (Diluted)	$22.88	$19.29	$17.31	$23.56	$30.88
EBITDA	$1.5B	$1.4B	$1.6B	$2.2B	$2.6B
Shares Outstanding	30M	32M	33M	33M	33M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$1.7B	$1.9B	$1.7B	$1.9B	$1.9B	$2.1B	$1.8B	$1.9B
Cost of Revenue	$1.1B	$1.2B	$535M	$415M	$628M	$651M	$1.1B	$1.1B
Gross Profit	$604M	$668M	$1.2B	$1.4B	$1.3B	$1.4B	$682M	$780M
Gross Margin	35.5%	35.9%	69.4%	77.7%	67.5%	68.4%	37.7%	40.5%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$392M	$586M	$494M	$502M	$509M	$463M	$444M	$477M
Operating Expenses	$392M	$396M	$987M	$502M	$1.0B	$1.1B	$444M	$457M
Operating Income	$212M	$272M	$224M	$943M	$298M	$356M	$238M	$323M
Operating Margin	12.5%	14.6%	12.8%	50.7%	15.4%	17.3%	13.1%	16.8%
Interest Expense	$53M	$64M	$61M	$68M	$63M	$82M	$78M	$121M
Income Before Tax	$232M	$254M	$255M	$286M	$274M	$316M	$197M	$517M
Tax Expense	$53M	$58M	$61M	$79M	$69M	$76M	$44M	$100M
Net Income	$179M	$196M	$194M	$207M	$205M	$239M	$152M	$417M
Net Margin	10.5%	10.5%	11.1%	11.1%	10.6%	11.6%	8.4%	21.7%
EPS (Diluted)	$5.46	$5.92	$5.88	$6.28	$6.25	$7.25	$4.66	$12.70
EBITDA	$500M	$540M	$543M	$531M	$554M	$633M	$502M	$549M
Shares Outstanding	33M	33M	33M	33M	33M	33M	33M	33M

KRSNAA.BO BSE